340 related articles for article (PubMed ID: 30962172)
1. Assessment of resection margins in bone sarcoma treated by neoadjuvant chemotherapy: Literature review and guidelines of the bone group (GROUPOS) of the French sarcoma group and bone tumor study group (GSF-GETO/RESOS).
Gomez-Brouchet A; Mascard E; Siegfried A; de Pinieux G; Gaspar N; Bouvier C; Aubert S; Marec-Bérard P; Piperno-Neumann S; Marie B; Larousserie F; Galant C; Fiorenza F; Anract P; Sales de Gauzy J; Gouin F;
Orthop Traumatol Surg Res; 2019 Jun; 105(4):773-780. PubMed ID: 30962172
[TBL] [Abstract][Full Text] [Related]
2. A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.
Jeys LM; Thorne CJ; Parry M; Gaston CL; Sumathi VP; Grimer JR
Clin Orthop Relat Res; 2017 Mar; 475(3):842-850. PubMed ID: 27138473
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
van der Woude HJ; Bloem JL; Verstraete KL; Taminiau AH; Nooy MA; Hogendoorn PC
AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
[TBL] [Abstract][Full Text] [Related]
4. Reporting Surgical Resection Margin Status for Osteosarcoma: Comparison of the AJCC, MSTS, and Margin Distance Methods.
Cates JM
Am J Surg Pathol; 2017 May; 41(5):633-642. PubMed ID: 28125453
[TBL] [Abstract][Full Text] [Related]
5. Surgical Resection Margin Classifications for High-grade Pleomorphic Soft Tissue Sarcomas of the Extremity or Trunk After Neoadjuvant Cytotoxic Therapy.
Cates VM; Cates JMM
Am J Surg Pathol; 2019 Jun; 43(6):844-850. PubMed ID: 30932925
[TBL] [Abstract][Full Text] [Related]
6. MRI Identification of the Osseous Extent of Pediatric Bone Sarcomas.
Thompson MJ; Shapton JC; Punt SE; Johnson CN; Conrad EU
Clin Orthop Relat Res; 2018 Mar; 476(3):559-564. PubMed ID: 29529641
[TBL] [Abstract][Full Text] [Related]
7. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
[TBL] [Abstract][Full Text] [Related]
8. Surface osteosarcoma: Predictors of outcomes.
Lee SJ; Lans J; Cook SD; Chebib I; Schwab JH; Raskin KA; Lozano-Calderón S
J Surg Oncol; 2021 Sep; 124(4):646-654. PubMed ID: 34043244
[TBL] [Abstract][Full Text] [Related]
9. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy.
Shamberger RC; LaQuaglia MP; Gebhardt MC; Neff JR; Tarbell NJ; Marcus KC; Sailer SL; Womer RB; Miser JS; Dickman PS; Perlman EJ; Devidas M; Linda SB; Krailo MD; Grier HE; Granowetter L
Ann Surg; 2003 Oct; 238(4):563-7; discussion 567-8. PubMed ID: 14530727
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection margin classifications for high-grade pleomorphic soft tissue sarcomas of the extremity or trunk: definitions of adequate resection margins and recommendations for sampling margins from primary resection specimens.
Cates MM; Cates JMM
Mod Pathol; 2019 Oct; 32(10):1421-1433. PubMed ID: 31053757
[TBL] [Abstract][Full Text] [Related]
11. [Place of the pathologist in the management of primary bone tumors (osteosarcoma and Ewing's family tumors after neoadjuvant treatment)].
Gomez-Brouchet A; Bouvier C; Decouvelaere AV; Larousserie F; Aubert S; Leroy X; Guinebretière JM; Coulomb A; Cassagnau E; de Muret A; Audard V; Marie B; de Pinieux G
Ann Pathol; 2011 Dec; 31(6):455-65. PubMed ID: 22172118
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma.
Lin PP; Jaffe N; Herzog CE; Costelloe CM; Deavers MT; Kelly JS; Patel SR; Madewell JE; Lewis VO; Cannon CP; Benjamin RS; Yasko AW
Cancer; 2007 Feb; 109(3):603-11. PubMed ID: 17177205
[TBL] [Abstract][Full Text] [Related]
13. Viable versus nonviable positive margins in Ewing sarcoma and associated recurrence rates: A systematic review.
El Demellawy D; Menzies-Toman D; Murphy M; Kabir N; Shaw A; Chernetsova E; Serlo JA; de Nanassy J
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e79-e90. PubMed ID: 31313497
[TBL] [Abstract][Full Text] [Related]
14. The width of resection margins influences local recurrence in soft tissue sarcoma patients.
Kainhofer V; Smolle MA; Szkandera J; Liegl-Atzwanger B; Maurer-Ertl W; Gerger A; Riedl J; Leithner A
Eur J Surg Oncol; 2016 Jun; 42(6):899-906. PubMed ID: 27107792
[TBL] [Abstract][Full Text] [Related]
15. Resection margins obtained with patient-specific instruments for resecting primary pelvic bone sarcomas: A case-control study.
Evrard R; Schubert T; Paul L; Docquier PL
Orthop Traumatol Surg Res; 2019 Jun; 105(4):781-787. PubMed ID: 30982774
[TBL] [Abstract][Full Text] [Related]
16. The safe surgical margin in Ewing's sarcoma.
Nogaro MC; Mifsud M; McCarthy C; Orosz Z; Pratap S; Craig R; Cosker TD; Gibbons C; Theologis T
Surg Oncol; 2022 May; 41():101737. PubMed ID: 35358914
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different.
Gaston LL; Di Bella C; Slavin J; Hicks RJ; Choong PF
Skeletal Radiol; 2011 Aug; 40(8):1007-15. PubMed ID: 21298431
[TBL] [Abstract][Full Text] [Related]
18. Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma.
Lozano-Calderón SA; Albergo JI; Groot OQ; Merchan NA; El Abiad JM; Salinas V; Gomez Mier LC; Montoya CS; Ferrone ML; Ready JE; Linares FJ; Levin AS; Peleteiro Pensado M; Pozo Kreilinger JJ; Ruiz IB; Ortiz-Cruz EJ; Gebhardt MC; Cote GM; Choy E; Spentzos D; Hung YP; Deshpande V; Chebib IA; McCulloch RA; Farfalli G; Aponte Tinao L; Morris CD; Petur Nielsen G; Anderson ME; Jeys LM
Cancer; 2023 Jan; 129(1):60-70. PubMed ID: 36305090
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
